“…It has been argued that an oncolytic virus should possess an ability to replicate in cancer cells that is large enough to cause effective oncolysis to allow for efficient antigen presentation, as tumors have a limited ability to recruit immune cells due to vascular compromise (43). If IFN-sensitive NDV can effectively replicate in tumor cells, it should be able to induce oncolysis.…”